UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026 Commission File Number 1-12260
COCA-COLA FEMSA, S.A.B. de C.V.
(Translation of registrant’s name into English)
United Mexican States
(Jurisdiction of incorporation or organization)
Calle Mario Pani No. 100, Santa Fe... (continue reading...)
Vanguard Short-Term Federal Fund
Supplement Dated September 3, 2026, to the Prospectus and Summary Prospectus Dated May 28, 2026
Important Change to Vanguard Short-Term Federal Fund
Fund Name Change
As previously announced, effective today, Vanguard Short-Term Federal Fund (the “Fund”) has changed its name to Vanguard Short-Term Government Securities Active Fund.
All references to the Fund are replaced with Vanguard Short-Term Government Securities Active... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of September 2026
Commission File Number: 001-36059
Controladora Vuela Compañía de Aviación, S.A.B. de C.V.
(Name of Registrant)
Av. Antonio Dovalí Jaime No. 70, 13 Floor, Tower B
Colonia Zedec Santa Fe
United Mexican States, Mexico... (continue reading...)
Filed Pursuant to Rule 424(b)(3)Registration No. 333-298483
PROSPECTUS
Up to 6,444,858 Shares of Common Stock Issuable Upon the Exercise of Pre-Funded Warrants, Common Warrants and Inducement Warrants
This prospectus relates to the resale from time to time by certain selling stockholders named herein (the “Selling Stockholders”) of up to 6,444,858 shares... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 AFLAC INC For: Sep 01 Filed by: Japan Post Holdings Co., Ltd.
-
Form SCHEDULE 13G/A SILVERCORP METALS INC Filed by: Helikon Investments Ltd
-
Form 497VPI Pruco Life Insurance Co
-
Form SCHEDULE 13G/A Allied Gold Corp Filed by: Helikon Investments Ltd
-
Form N-CEN DEUTSCHE DWS SECURITIES For: Jun 30
-
Form 497 Pruco Life Insurance Co
-
Form 485BXT GUINNESS ATKINSON FUNDS
-
Form 8-K CarGurus, Inc. For: Aug 28
-
Form 4 Better Home & Finance For: Sep 01 Filed by: Tuffin Paula
-
Form POS AM PRF Technologies Ltd.
-
Form 8-K Apogee Therapeutics, For: Sep 03
-
Form 8-K AbbVie Inc. For: Sep 03
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 425 Onconetix, Inc. Filed by: Onconetix, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K HF Foods Group Inc. For: Aug 31
-
Form 8-K Eightco Holdings Inc. For: Sep 03
-
Form 8-K TORO CO For: Sep 03
-
Form D/A Acadian Global All-Count
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 424B2 CITIGROUP INC
-
Form D/A Acadian Global All-Count
-
Form 6-K PRF Technologies Ltd. For: Jun 30
-
Form 424B2 CITIGROUP INC
-
Form F-6EF InSilico Medicine Cayman Filed by: Citibank,N.A./ADR
-
Form N-CSR HUSSMAN INVESTMENT TRUST For: Jun 30
-
Form D/A Acadian Sustainable Emer
-
Form D/A ACADIAN INTERNATIONAL
-
Form 6-K Steakholder Foods Ltd. For: Sep 03
-
Form 6-K Ruanyun Edai Technology For: Sep 03
-
Form 8-K SurgePays, Inc. For: Sep 02
-
Form 4 NORDSON CORP For: Sep 02 Filed by: Morris Milton Mayo
-
Form 6-K StealthGas Inc. For: Sep 03
-
Form D/A Acadian All Country Worl
-
Form 424B5 Jaguar Health, Inc.
-
Form 4 SMITH MIDLAND CORP For: Sep 01 Filed by: SMITH ASHLEY B
-
Form DEF 14C INNOVATE Corp. For: Sep 03
-
Form N-PX Second Line Capital, For: Jun 30
-
Form D/A Acadian Emerging Markets
-
Form 4 Horizon Kinetics Holding For: Sep 02 Filed by: Brennan Alice C
-
Form 6-K LOGPROSTYLE INC. For: Aug 31
-
Form 8-K Alaska Silver Corp. For: Sep 02
-
Form 6-K Baird Medical Investment For: Sep 03
-
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Oyegunwa Akinbolade
-
Form 10-Q Hewlett Packard Enterpri For: Jul 31
-
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Meltzer Jonathan C
-
Form 10-K/A PILLARSTONE CAPITAL REIT For: Dec 31
-
Form 4 LABCORP HOLDINGS INC. For: Sep 01 Filed by: Vaughn Bryan T
-
Form D/A Independent Access Partn
-
Form 424B3 LB PHARMACEUTICALS INC

